Ritholtz Wealth Management Invests $2.16 Million in Pediatrix Medical Group, Inc. $MD

Key Points

• Ritholtz Wealth Management bought 101,115 shares of Pediatrix Medical Group (NYSE:MD) in Q4, a stake valued at about $2.16 million and roughly 0.12% of the company.
• Institutional ownership is very high (97.71%), with large investors increasing positions — notably American Century Companies now holds 2,682,976 shares (~$44.94M) and Phocas Financial added 103,328 shares in the most recent filings.
• Analyst sentiment is mixed with a consensus "Hold" and an average price target of $19.80; the company recently missed quarterly EPS by $0.03 while reporting a slight revenue beat and a 8.64% net margin.

Ritholtz Wealth Management acquired a new position in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 101,115 shares of the company's stock, valued at approximately $2,163,000. Ritholtz Wealth Management owned about 0.12% of Pediatrix Medical Group as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Y Intercept Hong Kong Ltd purchased a new stake in shares of Pediatrix Medical Group in the third quarter worth approximately $513,000. Allianz Asset Management GmbH raised its stake in shares of Pediatrix Medical Group by 158.5% in the third quarter. Allianz Asset Management GmbH now owns 158,777 shares of the company's stock worth $2,660,000 after purchasing an additional 97,365 shares during the last quarter. Dana Investment Advisors Inc. raised its stake in shares of Pediatrix Medical Group by 5.6% in the third quarter. Dana Investment Advisors Inc. now owns 801,462 shares of the company's stock worth $13,424,000 after purchasing an additional 42,162 shares during the last quarter. Phocas Financial Corp. raised its stake in shares of Pediatrix Medical Group by 44.5% in the fourth quarter. Phocas Financial Corp. now owns 335,551 shares of the company's stock worth $7,177,000 after purchasing an additional 103,328 shares during the last quarter. Finally, American Century Companies Inc. raised its stake in shares of Pediatrix Medical Group by 38.9% in the third quarter. American Century Companies Inc. now owns 2,682,976 shares of the company's stock worth $44,940,000 after purchasing an additional 751,109 shares during the last quarter. 97.71% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several analysts have recently commented on MD shares. Deutsche Bank Aktiengesellschaft set a $19.00 price objective on Pediatrix Medical Group in a research note on Friday, February 20th. Truist Financial lowered their price objective on Pediatrix Medical Group from $24.00 to $21.00 and set a "hold" rating for the company in a research note on Thursday, February 19th. Jefferies Financial Group raised Pediatrix Medical Group to a "strong-buy" rating in a research note on Thursday, March 12th. Weiss Ratings reaffirmed a "hold (c+)" rating on shares of Pediatrix Medical Group in a research report on Friday, March 27th. Finally, Zacks Research downgraded Pediatrix Medical Group from a "strong-buy" rating to a "hold" rating in a research report on Friday, January 23rd. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and five have issued a Hold rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $19.80.

Pediatrix Medical Group Stock Performance

Shares of MD opened at $21.42 on Monday. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.66. The company has a market capitalization of $1.78 billion, a price-to-earnings ratio of 11.04 and a beta of 0.72. The stock has a 50 day moving average of $20.51 and a 200 day moving average of $20.62. Pediatrix Medical Group, Inc. has a 12 month low of $11.84 and a 12 month high of $24.99.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its quarterly earnings results on Thursday, February 19th. The company reported $0.50 EPS for the quarter, missing analysts' consensus estimates of $0.53 by ($0.03). The business had revenue of $493.77 million for the quarter, compared to analysts' expectations of $486.23 million. Pediatrix Medical Group had a net margin of 8.64% and a return on equity of 19.59%. The business's revenue was down 1.7% compared to the same quarter last year. During the same period in the previous year, the business posted $0.51 earnings per share. As a group, sell-side analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc NYSE: MD is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.

Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pediatrix Medical Group, Inc. (NYSE:MD - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.